United Therapeutics (BSP:U2TH34) Inventory Turnover : 0.56 (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is United Therapeutics Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. United Therapeutics's Cost of Goods Sold for the three months ended in Mar. 2025 was R$533 Mil. United Therapeutics's Average Total Inventories for the quarter that ended in Mar. 2025 was R$958 Mil. United Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.56.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. United Therapeutics's Days Inventory for the three months ended in Mar. 2025 was 164.10.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. United Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.21.

United Therapeutics Inventory Turnover Historical Data

The historical data trend for United Therapeutics's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Therapeutics Inventory Turnover Chart

United Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Inventory Turnover

Get a 7-Day Free Trial

1.34

1.42

1.49

2.33

2.50

United Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Inventory Turnover	Get a 7-Day Free Trial															0.63	0.63	0.59	0.52	0.56

United Therapeutics Inventory Turnover Calculation

United Therapeutics's Inventory Turnover for the fiscal year that ended in Dec. 2024 is calculated as

	Inventory Turnover (A: Dec. 2024 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2024 )	/ (	(Total Inventories (A: Dec. 2023 )	+	Total Inventories (A: Dec. 2024 ))	/	count )
=	1889.479	/ (	(547.798	+	963.348)	/	2 )
=	1889.479	/	755.573
=	2.50

United Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

	Inventory Turnover (Q: Mar. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2025 )	/ (	(Total Inventories (Q: Dec. 2024 )	+	Total Inventories (Q: Mar. 2025 ))	/	count )
=	532.625	/ (	(963.348	+	952.39)	/	2 )
=	532.625	/	957.869
=	0.56

United Therapeutics (BSP:U2TH34) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

United Therapeutics's Days Inventory for the three months ended in Mar. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2025 )	/	Cost of Goods Sold (Q: Mar. 2025 )	*	Days in Period
	=	957.869	/	532.625	*	365 / 4
	=	164.10

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

United Therapeutics's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2025 )	/	Revenue (Q: Mar. 2025 )
	=	957.869	/	4574.235
	=	0.21

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

United Therapeutics Inventory Turnover Related Terms

Thank you for viewing the detailed overview of United Therapeutics's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

United Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Therapeutics Corp (BSP:U2TH34) » Definitions » Inventory Turnover

Comparable Companies

Traded in Other Exchanges

UTHR:USA UTH:Germany UTH:Germany

Address

1000 Spring Street, Silver Spring, MD, USA, 20910

Website

https://www.unither.com

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

United Therapeutics Headlines

No Headlines